About the Speaker
Kirsten Rozemeijer, PhD, Epidemiologist
PostDoc
Department of Pathology, Amsterdam UMC
Dr. K. Rozemeijer holds three master's degrees in Biomedical Sciences, Public Health, and Epidemiology. She completed her PhD with a focus on using new screening tests in cervical cancer screening. After gaining five years of experience in Business Intelligence, she transitioned back to academia. Over the past three years, her research has concentrated on anal cancer screening, with a specific emphasis on epidemiology and the application of methylation testing.
Speaker Sessions
- EST
- Auditorium
- In-Person
Oral Abstracts - Research Forum 1 - Non-CME
- HSIL Risk After Negative Screening - Kirsten Rozemeijer
- Deep Learning and HPV Pleomorphic Multiorgans Induced Lesions: Automated Detection and Differentiation of Cervical and Anal Squamous Cancers Precursors - Miguel Mascarenhas
- Feminizing Gender-Affirming Hormone Therapy, HPV, and Precancerous Anal Lesions in High-Risk Populations: A Systematic Review - Manuel Valencia Echeverria
- Psychosocial Factors Associated with HPV Infection in Transgender Women in Argentina - Luciana La Rosa
- Risk Factors for Anal Human Papillomavirus (HPV) Infection and Anal HSIL Among Older Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) - Alexandra Hernandez
- Improving Screening Strategies for Detecting High-Grade Squamous Intraepithelial Lesions as a Predictor of Anal Cancer - Derek W. Ren
- The Addition of High-Risk HPV Testing as a Triage Tool in Anal Cancer Screening Optimizes the Referral Rate in a Canadian Cohort of Men Who Have Sex with Men Living with HIV - Troy Grennan
- Incidence of Anal High-Grade Squamous Intraepithelial Lesion (HSIL) Is High in Attendees of an Anal Cancer Screening Clinic in Vancouver, Canada: 2003-2021 - Troy Grennan
- EST
- Auditorium
- In-Person
Pathology and pathogenesis - Selected Oral Abstract Presentations - Non-CME
- Distinct Tumor Immune Microenvironment Profiles in Regressing versus Progressing Anal High-Grade Squamous Intraepithelial Lesions - Fernando Dias Gonçalves Lima
- Molecular Insights into the Natural History of Anal HSIL - Aude Jary
- Anal Swab-Specific Methylation Marker Discovery and Test Development for Objective Screening - Kirsten Rozemeijer
- Characterization of the Tumor Microenvironment of Premalignant and Malignant Anal Lesions - Cynthia Araradian
- EST
- Auditorium
- In-Person
Screening high risk groups - Selected Oral Abstract Presentations - Non-CME
- The Pilot of Anal Screening Study (PASS): Anal Cancer Screening in People Living with HIV - Clare Dyer
- Swab-based Anal Cancer Screening in HIV-Positive Men: Projected Outcomes for Different Screening Algorithms - Kirsten Rozemeijer
- 2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a Large Cohort of Persons with HIV - Michael Gaisa
- Perianal Lesions in MSM Living with HIV is an Underappreciated Risk for Precancer and Cancer - Shima Rastegar
